Derivation of RNA aptamer inhibitors of human complement C5

Immunopharmacology

Volumn 42, Issue 1-3, 1999, Pages 219-230

  Biesecker, Gregory ^a   Dihel, Larry ^a   Enney, Kristin ^a   Bendele, R A ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

Aptamer; C5; C5a; Complement; SELEX

Indexed keywords

CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT COMPONENT C5; COMPLEMENT INHIBITOR; RNA; ZYMOSAN;

COMPLEMENT INHIBITION; CONFERENCE PAPER; CONTROLLED STUDY; DNA BASE COMPOSITION; GENE AMPLIFICATION; HEMOLYSIS; HUMAN; HUMAN CELL; METHODOLOGY; MOLECULAR CLONING; PRIORITY JOURNAL; RNA SEQUENCE; RNA STRUCTURE; SEQUENCE HOMOLOGY;

ANIMALS; COMPLEMENT C5; COMPLEMENT INACTIVATOR PROTEINS; HEMOLYSIS; HUMANS; NUCLEIC ACID CONFORMATION; OLIGONUCLEOTIDES; RATS; RNA;

EID: 0033062077     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(99)00020-X     Document Type: Conference Paper

References (32)

1. Baldwin W.M. III, Pruitt S.K., Brauer R.B., Daha M.R., Sanfilippo F. Complement in organ transplantation: contributions to inflammation, injury, and rejection. Transplantation. 59:1995;797-808.
2. Bednar M.M., Gross C.E., Russell S.R., Short D., Giclas P.C. Activation of complement by tissue plasminogen activator, but not acute cerebral ischemia, in a rabbit model of thromboembolic stroke. J. Neurosurg. 86:1997;139-142.
3. Biesecker G., Gomez C.M. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6. J. Immunol. 142:1989;2654-2659.
4. Biesecker G., Katz S., Koffler D. Renal localization of the membrane attack complex (MAC) in SLE nephritis. J. Exp. Med. 39:1981;1779-1794.
5. Brauer R.B., Baldwin W.M. III, Ibrahim S., Sanfilippo F. The contribution of terminal complement components to acute and hyperacute allograft rejection in the rat. Transplantation. 59:1995;288-293.
6. Carroll M.C. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:1998;545-568.
7. Gasque P., Singhrao S.K., Neal J.W., Götze O., Morgan B.P. Expression of the receptor for complement C5a (CD88) is up- regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am. J. Pathol. 150:1997;31-41.
8. Green L.S., Jellinek D., Bell C., Beebe L.A., Feistner B.D., Gill S.C., Jucker F.M., Janjic N. Nuclease-resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem. Biol. 2:1995;683-695.
9. Haviland D.L., McCoy R., Whitehead W.T., Akama H., Molmenti P.E., Brown A., Haviland J.C., Parks W.C., Perlmutter D.H., Wetsel R.A. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyleloid cells of the liver and lung. J. Immunol. 154:1995;1861-1869.
10. Homeister J.W., Lucchesi B.R. Complement activation and inhibition in myocardial ischemia and reperfusion injury. Annu. Rev. Pharmacol. Toxicol. 34:1994;17-40.
11. Jellinek D., Green L.S., Bell C., Janjic N. Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor. Biochemistry. 33:1994;10450-10456.
12. Jellinek D., Green L.S., Bell C., Lynott C.K., Gill N., Vargeese C., Kirschenheuter G., McGee D.P.C., Abesinghe P., Pieken W.A., Shapiro R., Rifkin D.B., Moscatelli D., Janjic N. Potent 2′-amino-2′-deoxypyrimidine RNA inhibitors of basic fibroblast growth factor. Biochemistry. 34:1995;11363-11372.
13. Jensen K.B., Green L., MacDougal-Waugh S., Tuerk C. Characterization of an in vitro-selected RNA ligand to the HIV-1 Rev protein. J. Mol. Biol. 235:1994;237-247.
14. Kirschfink M. Controlling the complement system in inflammation. Immunopharmacology. 38:1997;51-62.
15. 7 RNA polymerase and synthetic DNA templates. Nucleic Acids Res. 12:1987;785-792.
16. Morgan B.P. Physiology and pathophysiology of complement: progress and trends. Crit. Rev. Clin. Lab. Sci. 32:1995;265-298.
17. Morgan B.P., Gasque P., Singhrao S.K., Piddlesden S.J. Role of complement in inflammation and injury in the nervous system. Exp. Clin. Immunogenet. 14:1997;19-23.
18. Mulligan M.S., Schmid E., Till G.O., Hugli T.E., Friedl H.P., Roth R.A., Ward P.A. C5a-dependent up-regulation in vivo of lung vascular P-selectin. J. Immunol. 158:1997;1857-1861.
19. Mulligan M.S., Schmid E., Beck-Schimmer B., Till G.O., Friedl H.P., Brauer R.B., Hugli T.E., Miyasaka M., Warner R.L., Johnson K.J., Ward P.A. Requirement and role of C5a in acute lung inflammatory injury in rats. J. Clin. Invest. 98:1998;503-512.
20. Nangaku M., Alpers C.E., Pippin J., Shankland S.J., Kurokawa K., Adler S., Johnson R.J., Couser W.G. Renal microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int. 52:1997;1570-1578.
21. Pagratis N.C., Bell C., Chang Y.F., Jennings S., Fitzwater T., Jellinek D., Dang C. Potent 2′-amino- and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Biotechnology. 15:1997;68-73.
22. Schmid E., Piccolo M.T.S., Friedl H.P., Warner R.L., Mulligan M.S., Hugli T.E., Till G.O., Ward P.A. Requirement for C5a in lung vascular injury following thermal trauma to rat skin. Shock. 8:1997;119-124.
23. Spencer M.J., Walsh C.M., Dorshkind K.A., Rodriguez E.M., Tidball J.G. Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J. Clin. Invest. 99:1997;2745-2751.
24. Spycher M.O., Nydegger U.E. Participation of the blood platelet in immune reactions due to platelet-complement interaction. Infus.Ther. Transfusionsmed. 22:1995;36-43.
25. Stahl G.L., Reenstra W.R., Frendl G. Complement-mediated loss of endothelium-dependent relaxation of porcine coronary arteries. Role of the terminal membrane attack complex. Circ. Res. 76:1995;575-583.
26. Sun L.Q., Wang L., Gerlach W.L., Symonds G. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA. Nucleic Acids Res. 23:1995;2909-2913.
27. Takahashi T., Saadi S., Platt J.L. Recent advances in the immunology of xenotransplantation. Immunol. Res. 16:1997;273-297.
28. Tuerk C., Gold L. Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science. 249:1990;505-510.
29. Wang Y., Hu Q., Madri J.A., Rollins S.A., Chodera A., Matis L.A. Amelioration of lupus-like autoimmune disease in NZB/W F1 mice after treatment with a blocking monoclonal antibody specific for complement component C5. Immunology. 93:1996;8563-8568.
30. Ward P.A. Role of complement in lung inflammatory injury. Am. J. Pathol. 149:1996;1079-1081.
31. Ward P.A. Recruitment of inflammatory cells into lung: roles of cytokines, adhesion molecules, and complement. J. Lab. Clin. Med. 129:1997;400-404.
32. Wetsel R.A., Kolb W.P. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments. J. Exp. Med. 157:1983;2029-2048.